Dr Natalie Cook
University of Manchester/Christie NHS Foundation Trust
Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester. She is also the clinical lead for Manchester Experimental Cancer Medicine Centre and is director for the MRes in Experimental Medicine at the University of Manchester. She previously trained in Medical Oncology in Cambridge, UK, where she completed a PhD, funded by a CRUK Clinical Training fellowship. In 2012, she was awarded the Rothwell Jackson Postgraduate Travelling Fellowship and travelled to Canada to undertake a 2 year drug development research fellowship, based at the University of Toronto and Princess Margaret Cancer Centre. In her current position she is co-investigator on a portfolio of over 50 early phase clinical trials, and is a Principal Investigator on over 20 trials.
Molecular testing and novel therapies in prostate cancer
This seminar will discuss the increasing use of molecular profiling and identified targets of interest in prostate cancer. It will also cover some aspects of the drug development process and how trial design is changing the route to registration for new therapeutics.
EVEN MORE SEMINARS
Suzanne Coupland Vision RT
Benefits of SGRT for patients receiving radiotherapy for Breast cancer
Lucinda Billingham University of Birmingham - Cancer Research Clinical Trials Unit
National Lung Matrix Trial: testing multiple novel targeted treatments
Dr Shanmugasundaram Ramkumar University Hospital Southampton NHS Foundation Trust
Radiotherapy developments in management of recurrent rectal cancers
Dr Catherine Coyle Christie Hospital NHS Foundation Trust
Prostate Cancer- the non surgical oncologists view
Neil Oakley Sheffield Teaching Hospitals NHS Trust
Robotic Radical Prostatectomy for Prostate cancer aiming for Trifecta 2020